Informed Consent Form (ICF) templates, Guidance relating to participant consent, and Protocol templates.
BC Cancer REB expects that all studies submitted for initial review conform to the ICF template, and specifically, include all language and/or sections marked as mandatory.
Important: Ensure that you are using the current version by returning to this page for templates as needed.
Clinical ICF was reviewed by the PHSA legal department updated in March 2022 (see
Notice: Informed consent documents).
Use the form below to document participants' wishes upon their decision to withdraw from a research study. BC Cancer REB's position is that the participants' wishes should
not be obtained at the time of initial ICF signing, but should be obtained once they express a desire to withdraw.
Please refer to the
UBC Behavioural Research Ethics Board (BREB) website for assistance with behavioural studies.
For studies using other institutions' templates but being submitted to the BC Cancer REB for review, please:
Replace contact information with BC Cancer contact:
"For questions about your rights as a research participant or privacy related questions, you can contact BC Cancer Research Ethics at email@example.com, or 604.877.6284. Please reference the study number Hxx-xxxxx when contacting Research Ethics so staff can better assist you. "
Insert the following wording when collecting information from participants:
"Federal and provincial privacy laws give safeguards for privacy, security, and authorized access to information. We will not give information that identifies you to anyone without your permission, except as required by law."
BC Cancer REB supports the use of the PHSA/BC Children's/BC Women's REDCap platform for use in research projects that are not regulated clinical trials. Please see below guidance for more information on e-consent:
Please note that the use of e-consent for Health Canada and FDA-regulated clinical trials requires specific considerations (see document page 3).